Results 251 to 260 of about 475,313 (268)
Some of the next articles are maybe not open access.
Cancer and venous thromboembolism
The Lancet Oncology, 2005Venous thromboembolism occurs commonly in patients with cancer. The pathogenetic mechanisms of thrombosis involve a complex interaction between tumour cells, the haemostatic system, and characteristics of the patient. Among risk factors for thromboembolism are long-term immobilisation, especially in hospital, surgery, and chemotherapy with or without ...
PRANDONI, PAOLO, FALANGA A, PICCIOLI A.
openaire +3 more sources
Chest, 2004
This article discusses the prevention of venous thromboembolism (VTE) and is part of the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines. Grade 1 recommendations are strong and
W. Geerts +6 more
semanticscholar +1 more source
This article discusses the prevention of venous thromboembolism (VTE) and is part of the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines. Grade 1 recommendations are strong and
W. Geerts +6 more
semanticscholar +1 more source
Cancer-associated venous thromboembolism
Nature Reviews Disease Primers, 2022A. Khorana +7 more
semanticscholar +1 more source
Current Opinion in Cardiology, 1991
During the past year, the findings of several clinical trials have been published that have important implications for the care of patients with venous thromboembolism. These clinical trials have produced advances in the diagnosis and treatment of venous thrombosis and pulmonary embolism and in the prevention of venous thromboembolism in high-risk ...
Gary E. Raskob, Russell D. Hull
openaire +3 more sources
During the past year, the findings of several clinical trials have been published that have important implications for the care of patients with venous thromboembolism. These clinical trials have produced advances in the diagnosis and treatment of venous thrombosis and pulmonary embolism and in the prevention of venous thromboembolism in high-risk ...
Gary E. Raskob, Russell D. Hull
openaire +3 more sources
Preventing venous thromboembolism
Nursing Management, 2005Learn to recognize who's at risk for potentially fatal complications and how to reduce your patient's risks.
openaire +5 more sources
Venous Thromboembolism Overview
Hematology/Oncology Clinics of North America, 2012This article gives a general overview of venous thromboembolism (VTE). Pathophysiology, presentation, diagnosis, and initial management of VTE are briefly reviewed. More difficult management problems are reviewed in greater depth, including duration of anticoagulation, treatment of superficial venous thrombosis, and controversies surrounding bridging ...
Jean M. Connors +2 more
openaire +3 more sources
Treatment of Venous Thromboembolism
Cardiology in Review, 2002Venous thromboembolism (VTE), comprised of pulmonary embolism (PE) and deep vein thrombosis (DVT), is a disease entity with a significant morbidity and mortality. Anticoagulation, initially with intravenous heparin and followed with long term warfarin treatment is the traditional therapy for VTE.
And George P Maguire +2 more
openaire +3 more sources
Vascular Medicine, 2012
A 61-year-old man was admitted to an outside medical facility with left leg deep vein thrombosis and bilateral pulmonary emboli. His clinical course was complicated by hypotension, azotemia and declining mental status. Positive blood cultures for gram-positive cocci prompted transfer to our institution.
Waldemar E. Wysokinski +2 more
openaire +3 more sources
A 61-year-old man was admitted to an outside medical facility with left leg deep vein thrombosis and bilateral pulmonary emboli. His clinical course was complicated by hypotension, azotemia and declining mental status. Positive blood cultures for gram-positive cocci prompted transfer to our institution.
Waldemar E. Wysokinski +2 more
openaire +3 more sources